Free Republic 2nd Qtr 2025 Fundraising Target: $81,000 Receipts & Pledges to-date: $72,343
89%  
Woo hoo!! And we're now over 89%!! Thank you all very much!! God bless.

Keyword: gild

Brevity: Headers | « Text »
  • Gold revaluation is already underway in the open by the BRICs,

    10/05/2024 9:05:30 PM PDT · by delta7 · 12 replies
    Gata ^ | 5 Oct 24 | Maguire
    Dear Friend of GATA and Gold: In this week's edition of Kinesis Money's "Live from the Vault" program, London metals trader Andrew Maguire outlines what he says are the many bullish drivers of the gold price. He says Chinese central bank buying remained strong this week though retail buying was absent because of the "Golden Week" holidays. Indian central bank buying remained strong as well, Maguire says. Using price charts, Maguire says central bank buying is steadily driving up the gold price in calculated stair steps that prevent the physical market from becoming too disorderly. Now that the BRICs nations...
  • Sovaldi's Terrific Launch (Gilead's Hep C drug, perhaps biggest seller ever)

    03/25/2014 10:49:56 AM PDT · by RoosterRedux · 17 replies
    seekingalpha.com ^ | 3/17/2014 | Peter Geschek
    Gilead Sciences' (GILD) Sovaldi is now projected to become the best-selling medicine of all time by several analysts. Sovaldi is the first in a new wave of Hep C treatments that promise better cure rates and a shorter treatment course. Some even forecast it would reach $9 billion or more in sales by 2017, at which level it would surpass Pfizer's (PFE) Lipitor and take the crown as the biggest-selling drug of all time. Analysts are trying to outdo each other with optimistic forecasts. According to ISI Group analyst Mark Schoenebaum, if prescriptions were to never grow again, that is...